Clin2
NCT06402968Possibly a fitRecruiting

Clevidipine for treating high blood pressure after a brain bleed

Intracerebral HemorrhageStrokeHypertension

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests a blood pressure medicine called clevidipine given through an IV to people with a brain bleed (intracerebral hemorrhage). The goal is to see if quickly lowering blood pressure helps prevent more bleeding and improve recovery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,018 people
Ages
18 years to 100 years
Study type
Observational

Who can take part

  • You are 18 to 99 years old.
  • Your stroke symptoms began within the last 12 hours.
  • A CT scan shows a brain bleed larger than 5 mL (not just tiny spots).
  • Your blood pressure on arrival was between 150 and 220 mmHg.
  • You are not pregnant, breastfeeding, or had a baby in the last 30 days.
  • You are not allergic to soybeans, eggs, or similar medications.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06760078Not yet recruiting· Phase 4
Early drug and blood pressure control for brain bleeding

This trial tests whether giving a drug called tranexamic acid (helps stop bleeding) along with very careful blood pressure lowering can reduce bleeding growth and improve recovery after a brain bleed. It is for people who arrive at the hospital very quickly (within 2 hours) after symptoms start.

Beijing, Beijing Municipality
NCT07695220Not yet recruiting
Medication for early blood pressure control after brain bleed

This study tests two sedative medications, remifentanil and dexmedetomidine, to lower blood pressure quickly after a brain bleed (intracerebral hemorrhage). High blood pressure right after a bleed can cause more damage, so this trial aims to see if these drugs help improve recovery.

NCT07279259Recruiting· Phase 2
Blood pressure management after stroke clot-dissolving treatment

This trial tests how managing high blood pressure during clot-dissolving treatment for acute ischemic stroke affects recovery. It is for patients who have high blood pressure at the start of treatment.

Shanghai
NCT06899464Not yet recruiting· Phase 4
Testing cerebrolysin for bleeding stroke within 6 hours

This study tests a drug called Cerebrolysin, which may help protect the brain after a bleeding stroke. It is given within 6 hours of the stroke, and researchers will check if it is safe and helps improve recovery.

NCT07458880Recruiting
Triple blood pressure pill after a brain bleed

This trial tests whether a combination of three blood pressure medicines can better control blood pressure after a brain bleed (intracerebral hemorrhage). It may help prevent another bleed or stroke.

Hong Kong, Hong Kong
NCT07365150Recruiting
Tranexamic acid for brain bleeding

This study tests whether the drug tranexamic acid can help stop bleeding in the brain when given early. It is for people with a spontaneous brain bleed who are awake and can be treated within 6 hours.

Hong Kong

Hear when a new Intracerebral Hemorrhage trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.